Affirm (AFRM) Form 4: 184,200-Share Option Exercise and Sale Reported
Rhea-AI Filing Summary
Linford Michael, Chief Operating Officer of Affirm Holdings, Inc. (AFRM), reported transactions on 08/22/2025 conducted under a Rule 10b5-1 trading plan adopted February 14, 2025. On that date he exercised stock options to acquire 184,200 shares of Class A Common Stock at an exercise price of $5.39 per share and concurrently sold 184,200 shares at a weighted average sale price of $80.09 per share. The filing reports 294,040 shares beneficially owned following the acquisition step and 109,840 shares beneficially owned following the sale. The Form 4 discloses the option terms: the options are exercisable and vesting details reference an August 27, 2018 commencement with remaining vesting through three years thereafter.
Positive
- Transactions were executed under a disclosed Rule 10b5-1 trading plan adopted February 14, 2025
- Weighted average sale price reported for the disposed shares at $80.09 per share (range $80.00–$80.40 disclosed)
Negative
- Reporting person disposed of 184,200 shares on 08/22/2025
- Beneficial ownership declined to 109,840 shares following the reported sale
Insights
TL;DR: Insider exercised options and sold shares under a 10b5-1 plan; reported holdings changed materially on 08/22/2025.
The reporting shows a contemporaneous exercise of 184,200 options at $5.39 and sale of 184,200 shares at a weighted average price of $80.09, implemented under a 10b5-1 plan adopted Feb 14, 2025. Such plans provide an affirmative defense to insider trading claims when properly adopted and followed. The filing supplies specific post-transaction beneficial ownership figures (294,040 and 109,840) and restates vesting schedule language tied to an August 27, 2018 commencement date.
TL;DR: Transactions were executed pursuant to a documented 10b5-1 plan, and the Form 4 includes standard vesting and signature disclosures.
The Form 4 identifies the reporting person as the COO and notes the transactions were effected pursuant to a 10b5-1 trading plan adopted Feb 14, 2025, which is explicitly disclosed in the explanation. The filing includes the weighted average sale price range detail and indicates an attorney-in-fact signature. This disclosure follows standard Section 16 reporting practice and supplies the required post-transaction beneficial ownership counts.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 184,200 | $0.00 | -- |
| Exercise | Class A Common Stock | 184,200 | $5.39 | $993K |
| Sale | Class A Common Stock | 184,200 | $80.09 | $14.75M |
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2025. Represents the weighted average sale price of the shares sold from $80.00 to $80.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Stock options vest with respect to 1/4 of the shares of the Issuer's Class A common stock, par value $0.00001 per share ("Class A Common Stock"), underlying the stock option on the one-year anniversary of August 27, 2018, the vesting commencement date, and the remaining 3/4 of the shares underlying the option vest in equal monthly installments over the subsequent three years, in each case subject to continued service with the Issuer. The Reporting Person can elect to exercise the stock options at any time, provided that the shares acquired upon exercise remain subject to the applicable vesting schedule.
